TNFRSF11A and bone remodeling disease: Indeed, OBs synthesize OPG, a soluble decoy receptor for RANKL, which is involved in the competitive inhibition of RANK/RANKL signaling, thereby preventing RANK and OC activation in several bone remodeling diseases [38].